Connect with us

Health/medicine

New advanced treatments offer hope for multiple myeloma patients

Published

on

New Delhi, March 20 (IANS) Once known to be a dreaded disease with a short lifespan, patients with multiple myeloma now have better treatment outcomes with medical advancements like bone marrow transplant, immunotherapy and CAR T-cell therapy, said health experts on Wednesday.

Multiple myeloma is a blood cancer that arises from plasma cells — a type of cell normally present in the bone marrow and blood in small numbers. Their function is to produce antibodies that fight against infections. But, when these cells start dividing uncontrollably and spread abnormally in the body, it leads to multiple myeloma.

“Myeloma, also known as multiple myeloma, is a cancer of plasma cells, which despite the various complexities, can still be cured. Bone marrow transplant is one of the effective treatments for multiple myeloma. Hematopoietic stem cells reside in the bone marrow. In this procedure, hematopoietic stem cells are collected from the patient or another person,” Rahul Bhargava, Director, Department of Clinical Hematology & Bone Marrow Transplant, Fortis Hospital Gurugram told IANS.

ALSO READ:  Study links cannabis use with 11x higher risk of psychotic disorder

“Myeloma, till a few years back, was a dreaded disease with a lifespan of only a few years. Advancements in newer methods like immunotherapy and CAR T-cell therapy promise better treatment outcomes. This has led to an increase in survival which is now more than 7-8 years, even more than a decade in many patients. The survival is further increased by doing the bone marrow transplant in these patients in a hospital setting,” added Ashish Gupta, a multiple myeloma expert and Chief of Medical Oncology at Unique Hospital Cancer Centre, Delhi.

Unexplained kidney failure, back pain with broken bones as well as long-term anaemia, fatigue and infections in the urine are some of the common symptoms of the disease.

“In multiple myeloma patients now survival is longer. Medications do not cause hair loss, and they are now slowly moving from intravenous to subcutaneous, like a jab for an insulin injection and along with oral medications which are making life very easy for patients with myeloma,” Ashish Gupta told IANS.

ALSO READ:  Nicotine replacement therapy may help smokers quit by 70pc, cut withdrawal symptoms

Rahul Bhargava noted that BMT’s success in multiple myeloma patients depends on early treatment.

“Too much delay in the procedure can considerably affect the clinical outcomes. In patients, recovery is 90 per cent, who received the treatment within the recovery time-frame,” the doctor said.

–IANS

rvt/svn

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health/medicine

PM Modi hails Sudha Murty's maiden Rajya Sabha speech on women’s health

Published

on

By

New Delhi, July 3 (IANS) Prime Minister Narendra Modi on Wednesday commended author and philanthropist Sudha Murty — newly elected to the Rajya Sabha — for her impactful maiden speech during the discussion on motion of thanks to the President’s Address in the Upper House of the Parliament.

Speaking about women’s health, she cited her father’s poignant remark – when a mother dies it is counted as one death in the hospital, but for the family, a mother is lost forever.

PM Modi expressed gratitude to Sudha Murty for her comprehensive discussion on women’s health, acknowledging her as she stood up and greeted him.

“I want to thank Sudha Murty for speaking in detail about women’s health,” PM Modi said.

While discussing Sudha Murty’s emotional remarks about mothers, the Prime Minister emphasised that over the past decade, his government has prioritised women’s health and sanitation as a crucial sector.

“Our country’s women have benefited from the toilets we have made,” PM Modi said while replying to a debate on a motion thanking President Droupadi Murmu for her address to the joint sitting of Parliament last week.

ALSO READ:  Dr Reddy's launches cancer drug in the UK

PM Modi also highlighted that his government has distributed sanitary pads and launched a vaccination program for pregnant women.

Sudha Murty advocated for a government-backed vaccination programme aimed at combatting cervical cancer.

“There is a vaccination which is given to girls, between the age of nine and 14, known as a cervical vaccination. If the girls take that, it (cancer) can be avoided… we should promote vaccination for the benefit of our girls because prevention is better than cure,” she said in her first speech in Rajya Sabha.

She suggested that since the government successfully managed a significant vaccination drive during Covid-19, providing cervical vaccination to girls aged 9-14 years should not be very challenging.

Sudha Murty, nominated to the Upper House of the Parliament by President Droupadi Murmu on the eve of International Women’s Day, noted that the cervical vaccination, developed in the West, has been in use for the past 20 years.

“It worked very well. It is not expensive. Today, it is Rs 1,400 for people like me who are in the field. If the government intervenes and negotiates… you can bring it to Rs 700-800. We have such a large population. It will be beneficial for our girls in the future,” she said during her 13-minute address.

ALSO READ:  Scientists finds more evidence on Covid's effect on cognition, memory

–IANS

brt/pgh

Continue Reading

Health/medicine

India backs global standards for spices, vegetable oils at international food trade meet

Published

on

By

New Delhi, July 3 (IANS) India has backed global standards for spices and vegetable oils at the 86th session of the Executive Committee (CCEXEC) of the Codex Alimentarius Commission (CAC), the Ministry of Health and Family Welfare (MoHFW) said on Wednesday.

The CCEXEC, ongoing at Food and Agriculture Organization (FAO) headquarters in Rome from July 1-5, plays a critical role in reviewing proposals for new work and monitoring the progress of standards development.

The CAC, an international body established by the FAO and the World Health Organisation (WHO), aims to protect consumer health and promote fair practices in food trade.

During the session, India, represented by G. Kamala Vardhana Rao, CEO of the Food Safety and Standards Authority of India (FSSAI), strongly supported the advancement of standards development for various spices, including small cardamom, turmeric, and vanilla, the ministry said.

“This initiative is particularly significant for India, being a major producer and exporter of these spices, as it would facilitate smoother international trade,” it added.

ALSO READ:  Nicotine replacement therapy may help smokers quit by 70pc, cut withdrawal symptoms

India also “backed the progression of standards for named vegetable oils, guidelines for the control of Shiga toxin-producing Escherichia coli”.

It also called for the safe use and reuse of water in food production and processing and championed the proposal for developing Codex guidance on food safety considerations related to the use of recycled materials in food packaging.

It is “crucial in addressing global challenges such as climate change, environmental protection, and sustainability,” the ministry said.

Further, at the session, India shared its experience with the FSSAI guidelines on recycling post-consumer PET for food contact applications. “India’s participation, as a member, in the High-level Executive Committee (CCEXEC) underscores its dedication to establishing robust food safety standards and promoting fair practices in the global food trade, reflecting its pivotal role in the international food industry,” the ministry noted.

–IANS

rvt/vd

Continue Reading

Health/medicine

New AI model to boost patient response to cancer therapy

Published

on

By

New Delhi, July 3 (IANS) Australian researchers have developed a new artificial intelligence (AI) tool that can help to select the most suitable treatment for cancer patients.

The new tool DeepPT, developed by researchers at The Australian National University (ANU), predicts a patient’s messenger RNA (mRNA) profile.

This mRNA — essential for protein production — is also the key molecular information for personalised cancer medicine.

When combined with another tool called ENLIGHT, DeepPT was found to successfully predict a patient’s response to cancer therapies across multiple types of cancer, said lead author Dr Danh-Tai Hoang from ANU.

Dr Hoang said, “DeepPT was trained on over 5,500 patients across 16 prevalent cancer types, including breast, lung, head and neck, cervical and pancreatic cancers”.

The tool, detailed in the journal Nature Cancer, showed an improvement in patient response rate. The AI tool draws on microscopic pictures of patient tissue called histopathology images, also providing another key benefit for patients.

ALSO READ:  World No Tobacco Day: Mothers pledge to protect children from promotion of new-age gateway devices

“This cuts down on delays in processing complex molecular data, which can take weeks,” Dr Hoang said, as any delay can affect patients with high-grade tumours who might require immediate treatment.

“In contrast, histopathology images are routinely available, cost-effective, and timely,” Hoang added.

–IANS

rvt/uk

Continue Reading

Health/medicine

Limit ghee, coconut oil if you have fatty liver disease: Expert

Published

on

By

New Delhi, July 3 (IANS) As fatty liver disease is increasing in India, a noted hepatologist on Wednesday advised limiting consumption of saturated fats like ghee and coconut oil.

Fatty liver disease is related to obesity and diabetes. Consuming excessive carbohydrates can raise insulin levels, and chronic high insulin levels lead to insulin resistance. This disrupts metabolism and converts excess glucose into fatty acids, which are stored in the liver.

It can be classified into two main types: alcoholic fatty liver disease (AFLD) and non-alcoholic fatty liver disease (NAFLD/MASLD) — linked to liver inflammation and damage, eventually leading to fibrosis, cirrhosis, or liver cancer.

“In the Indian context, if you have metabolic-disorder-associated fatty liver disease (previously NAFLD), remember to limit saturated fat sources in your diet,” said Dr Abby Phillips, popularly known as LiverDoc, on the social media platform X.com.

“This means limiting foods containing Ghee, clarified butter (north India), Coconut oil (south India), and Palm oil (processed/ ultra-processed foods),” he explained, adding that “saturated fats increase liver triglycerides and hence liver fat and inflammation.”

ALSO READ:  World No Tobacco Day: Mothers pledge to protect children from promotion of new-age gateway devices

While ghee is traditionally considered healthy, the doctor noted that it “is not a superfood. It is a super danger. It is almost all fat, and more than 60 per cent is saturated (unhealthy) fat.”

He stressed the need to replace it with “healthier (vegetable) seed oils that have low saturated fat and trans-fat content.”

Dr Abby also recommended using a diverse range of seed oils in daily cooking. Instead of frying food items, he suggested “bake, boil, broil, grill, or steaming foods.”

He also called out to “increase portions of plant-based protein in daily meals and to add daily fresh cut fruit portions (instead of fruit juicing).”

“This is far more important than limiting meat (including lean meat more than red meat), fish, and eggs — all of which can be consumed in their recommended daily/weekly intake,” the doctor said.

–IANS

rvt/sd/kvd

Continue Reading

Health/medicine

Aspirin can prevent complications in pregnancy caused by flu infections: Study

Published

on

By

New Delhi, July 3 (IANS) Taking low-dose aspirin may treat flu-induced blood vessel inflammation, creating better blood flow to the placenta during pregnancy, according to the world-first study conducted in mice.

Low-dose aspirin is commonly taken to prevent preeclampsia — high blood pressure condition in pregnancy — as it stops the body from creating chemicals that cause inflammation.

The study, led by an international team from RMIT University in Australia in collaboration with a team from Trinity College Dublin, Ireland, examined whether the treatment for preeclampsia could be applied to flu infections.

They found very promising results in animal studies — mice treated daily with low-dose aspirin had less inflammation and improved foetal development and offspring survival.

On the contrary, foetuses and placenta from mice with influenza A were smaller than those from uninfected mice. They also found the foetuses with low blood oxygen and poor blood vessel development.

Flu infections during pregnancy can resemble preeclampsia, a pregnancy complication that causes inflammation to the aorta and blood vessels, said lead researcher Dr Stella Liong, a post-doctoral research student at RMIT University in Melbourne.

ALSO READ:  Scientists finds more evidence on Covid's effect on cognition, memory

She explained: “When the vascular system gets inflamed, it leads to poor blood flow and affects the aorta’s function.”

“This is especially a problem during pregnancy where good blood flow to the placenta is crucial to the development of the foetus.”

While the research still awaits human clinical trials, Liong said low-dose aspirin is already recognised as safe to take during pregnancy.

However, pregnant people must seek medical advice before taking new medications, the research team said.

–IANS

rvt/sd/kvd

Continue Reading

Trending